Table 3.
Characteristics of MoCA test completers and non-completers at 16 weeks after RT.
| Total (n = 278 a) |
Completers (n = 167) |
Non-Completers (n = 111) |
p-Value b |
Non-Completers, Deceased (n = 36) |
Non-Completers, Alive (n = 75) |
|---|---|---|---|---|---|
| Baseline MoCA score, mean (SD) Age, mean (SD) Gender, n (%) Male Female Education, n (%) (1 missing) Compulsory Secondary College or university Comorbidity, CCI, mean (SD) Number of daily medications, mean (SD) Geriatric depression scale ≥5, n (%) No Yes |
24.7 (3.3) 72.9 (5.9) 81 (48.5) 86 (51.5) 48 (28.7) 68 (40.7) 51 (30.5) 1.0 (1.3) 5.0 (3.5) 136 (81.4) 31 (18.6) |
22.9 (4.1) 74.2 (6.7) 63 (56.8) 48 (43.2) 33 (29.7) 47 (42.3) 30 (27.0) 1.2 (1.5) 6.1 (3.7) 82 (73.9) 29 (26.1) |
˂0.001 c 0.107 c 0.177 d 0.843 d 0.246 c 0.020c 0.133 d |
21.9 (4.5) 74.2 (7.1) 26 (72.2) 10 (27.8) 12 (33.3) 15 (41.7) 9 (25.0) 1.6 (1.4) 7.6 (3.4) 26 (72.2) 10 (27.8) |
23.4 (3.8) 74.2 (6.5) 37 (49.3) 38 (50.7) 21 (28.0) 32 (42.7) 21 (28.0) 1.0 (1.5) 5.3 (3.7) 56 (74.7) 19 (25.3) |
| Number of physical impairments, mean (SD), (3 missing) Fatigue, mean (SD) (3 missing) RT treatment intent, n (%) Curative Palliative Previous cancer treatment, n (%) Endocrine therapy Other systematic cancer therapy Cancer surgery/RT Cancer/metastases in the brain, n (%) No Yes |
0.9 (1.1) 34.3 (23.9) 111 (66.5) 56 (33.5) 38 (22.8) 42 (25.1) 115 (68.9) 162 (97.0) 5 (3.0) |
1.9 (1.7) 43.1 (27.2) 40 (36.0) 71 (64.0) 15 (13.5) 42 (37.8) 56 (50.5) 101 (91.0) 10 (9.0) |
˂0.001 c 0.005 c ˂0.001 d 0.163 d 0.024 d 0.002 d 0.030 d |
2.5 (1.6) 58.7 (22.8) 2 (5.6) 34 (94.4) 4 (11.1) 19 (52.8) 16 (44.4) 28 (77.8) 8 (22.2) |
1.6 (1.6) 35.7 (26.0) 38 (50.7) 37 (49.3) 11 (14.7) 23 (30.7) 40 (53.3) 73 (97.3) 2 (2.7) |
a Accounting for protocol exceptions (n = 20), i.e., patients recruited from municipalities that did not participate in performing the mGA during follow-up. Of the 39 patients that were deceased by 16 weeks after RT, 3 were recruited from such municipalities. b p-value represents comparison of MoCA completers and all non-completers, irrespective of cause, 16 weeks after RT. c Independent samples t-test. d χ2-test. p-values marked with bold indicate statistically significant differences.